Search
Medicaid Monitor
Monday, October 26, 2026 · Updated 6:06 AM MT · 15 stories today
Mon, Oct 26 · 15 stories todayPRO
← All stories
LegalOctober 23, 2026

House Committee Investigates PBMs Over Alleged Retaliatory Pharmacy Audits

The House Committee on Oversight and Government Reform launched an investigation Oct. 23 into pharmacy benefit managers Optum Rx, CVS Caremark and Express Scripts, examining whether independent pharmacies were targeted with punitive audits for publicly supporting HR 6610. Chairman James Comer said audit notices increased after a July committee markup of the bill, which would require PBMs serving Federal Employees Health Benefits Program plans to pay pharmacies a capped benchmark price and a dispensing fee tied to state Medicaid rates. The committee cited one audit over a $0.99 medication that consumed hundreds of staff hours at an independent pharmacy. CVS said it will respond to the committee's letter; Optum Rx declined comment and Express Scripts has not yet responded.

Why it mattersThe probe could expose PBM audit practices to congressional scrutiny and shape pharmacy reimbursement rules that reference state Medicaid dispensing fee benchmarks, directly affecting Medicaid pharmacy networks and independent pharmacy sustainability.

Pharmacy

Read the full article at beckershospitalreview.com →
Share this briefing

You might also like

← All stories

Get the daily briefing.